Articles On Zelda Therapeutics (ASX:ZLD)

Title Source Codes Date
ASX Health Stocks: Nyrada gets closer to European patent, and HOPE for Zelira’s autism tincture

Nyrada’s European patent submission gets a patent number Zelira’s positive study results on its autism tincture, HOPE  Beamtree gives beaming trading update Cardiovascular and neurological diseases fighter, Nyrada (ASX: NYR), says the Eur...

Stockhead ZLD 1 year ago
Market Highlights and 5 ASX Small Caps to watch on Tuesday

ASX to open higher as Wall Street returns a mixed bag Oil prices are higher by 3% El Salvador to host a Bitcoin summit with 44 other countries/institutions Aussie shares are set to open higher this morning, despite a mixed bag of results...

Stockhead ZLD 1 year ago
Weed Week: US seed bank launches 4/20 day NFT collection and Washington has a cannabis tax holiday

US Seed Connect launched Cannabis Crypto Seed Headz NFT Washington launches week-long cannabis tax holiday Medlab clinical makes moves in the Northern Hemisphere with manufacturing deal Wednesday was 4/20 day – while it’s more of an unoff...

Stockhead ZLD 1 year ago
Zelira Therapeutics executes acquisition of Health House

Zelira Therapeutics (ASX:ZLD) has announced it has executed a binding scheme implementation deed under which it proposes to acquire 100 per cent of Health House.

BiotechDispatch ZLD 1 year ago
Weed Week: New York hemp farmers get green light for cannabis crops

Hemp farmers in New York have been given the go ahead to plant cannabis for the 2022 season. The legislation allows conditionally licensed cannabis farmers to grow weed, but they must meet certain requirements, including safe, sustainable a...

Stockhead ZLD 2 years ago
ASX Health Stocks: Here’s a highlight from today’s half-year result announcements

At the time of writing, the ASX 200 Health Index (XHJ) is down by 1.10%, while the benchmark ASX 200 has fallen by 2.15%. It’s all about earnings today for ASX health stocks. Here’s a highlight of where they stand in the first half.   Round...

Stockhead ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) set to acquire Health House International

Zelira Therapeutics (ZLD) is set to take over Health House International to expand the market reach of its medicinal cannabis products Under the scheme, Zelira will issue shares to Health House parties at 19.45 per cent interest in the exp...

themarketherald.com.au ZLD 2 years ago
Board changes for Zelira Therapeutics

Zelira Therapeutics (ASX:ZLD), a company focused on the development of clinically validated cannabis medicines, has appointed Tim Slate as a non-executive director.

BiotechDispatch ZLD 2 years ago
ASX Health Stocks: Immuron up 29pc on $6.2m travellers’ diarrhoea clinical study for US military

Immuron nabs $6.2m clinical research deal for US Military strength Travelan dose ECS Botanics reports record revenue of $1.5m expected for Q2 FY22 Compumedics secures first major magnetoencephalography (MEG) sale in China Immuron (ASX:IMC...

Stockhead ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) receives $1.29 million cash R&D incentive

Zelira Therapeutics (ZLD) has received a $1.29 million cash refund under the Federal Government’s research and development tax incentive scheme. The cash was part of a program under which companies receive refunds for eligible expenditure...

themarketherald.com.au ZLD 2 years ago
Zelira (ASX:ZLD) paid US$250,000 for cannabinoid technology

Zelira Therapeutics (ZLD) has received US$250,000 (A$348,000) for its technology which enables the enhanced dissolution of cannabinoids The company expects to receive the full US$1 million upfront, non-refundable, non-contingent licence pa...

themarketherald.com.au ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) expands into New Zealand

Zelira Therapeutics (ZLD) expands into the New Zealand cannabinoid-based medicines market via a five year exclusive distribution agreement with NUBU Pharmaceuticals The deal allows Zelira to market its Zenivol and Hope 1 products in New Ze...

themarketherald.com.au ZLD 2 years ago
ASX Health Stocks: CSL drags Healthcare index down 5pc on a mammoth $6.3bn cap raise

The ASX 200 Health Index (XHJ) has dropped by almost 5% at the time of writing, compared to the broader index which is down by 0.20%. Healthcare giant and blood specialist, CSL (ASX:CSL), which makes up a large part of the ASX Healthcare in...

Stockhead ZLD 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Thursday

Wall Street rallies on Fed decision US stocks rallied strongly overnight, as investors digested the central bank’s decision to speed up its tapering program and hike rates next year. Fed Reserve governor Jerome Powell said the bank will red...

Stockhead ZLD 2 years ago
Zelira Therapeutics confirms ethics approval for chronic pain study

Zelira Therapeutics (ASX:ZLD) has announced ethics approval has been granted for the Phase 2a clinical trial of its cannabinoid formulation, ZTL-106, in treating patients with chronic pain.

BiotechDispatch ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) granted ethics approval for chronic pain trial

Zelira Therapeutics (ZLD) receives ethics approval for its Phase 2a clinical trial for chronic pain As part of its licensing and project management with Levin Health, the study will evaluate the efficacy of Zelira’s cannabinoid formulation...

themarketherald.com.au ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) signs US$1m licensing deal

Zelira Therapeutics (ZLD) signs a licensing deal for its Enhanced Distillate Capture and Dissolution Matrix (EDCDM) technology DRCN Holding will pay a US$1 million (A$1.35 million) licensing fee for the tech and has three years to develop...

themarketherald.com.au ZLD 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Wednesday

Fresh record highs on Wall Street ahead of Fed statement US stocks continued their strong recent run overnight, and finished at fresh record levels for the third day in a row. All three benchmarks indexes rose – the Dow Jones rose by 0.39%,...

Stockhead ZLD 2 years ago
Closing Bell: ASX shrugs it off with another day of gains as investors clamour for more IPOs

As the world emerges from the pandemic, markets are now contending with an energy crisis, a global shipping glut and the prospect of central banks starting to raise interest rates. But so far this week, investors are shrugging it all off as...

Stockhead ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) recieves funding from Quincy Street

Zelira Therapeutics (ZLD) raises US$5 million (around A$6.69) from US family office fund, Quincy Street Capital Quincy Street has now become a substantial shareholder in Zelira with a 6.3 per cent stake Funds from the raise will be used to...

themarketherald.com.au ZLD 2 years ago
Closing Bell: ASX fails to maintain gains, despite tech gaining 1.7pc

Just like yesterday the ASX rallied for most of the day but retreated in the afternoon and today closed in the red. The ASX 200 was down 0.08% at 7,375 points. Another difference from yesterday was tech was the best sector gaining 1.7% whil...

Stockhead ZLD 2 years ago
Zelira Therapeutics (ASX:ZLD) enters trading halt ahead of capital raise

Zelira Therapeutics (ZLD) calls a two-day trading halt as it gears up to raise some fresh funds The company is yet to announce how much it plans to raise or for what it will use the funding boost Taking a look at Zelira’s latest financial...

themarketherald.com.au ZLD 2 years ago
Weed Week: Amazon scraps marijuana drug tests and Victorian council considers cannabis crops

Retail giant Amazon has rejigged its cannabis policy, allowing employees who were previously fired for testing positive for marijuana to reapply for jobs. The company has now excluded marijuana from its comprehensive pre-employment drug scr...

Stockhead ZLD 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Thursday

Wall Street higher as US Fed firms up November tapering US stock markets were higher overnight, as US Fed Chairman Jerome Powell signalled the bank would start tapering its asset purchases starting in November, which would last until the mi...

Stockhead ZLD 2 years ago
Market Highlights and 5 ASX Small Caps to watch on Monday

Wall Street slips as iron ore falls further All three US stock market indexes fell on Friday, ahead of the US Fed rates decision this Wednesday (US time). The Dow Jones fell by 0.48%, S&P500 by 0.91%, and the tech heavy Nasdaq also fell...

Stockhead ZLD 2 years ago
Hidden Gems Webinar Recap – ZLD, WTL, AGN, CLA

ShareCafeHidden Gems Webinar Recap – ZLD, WTL, AGN, CLA Catch up on the full webinar with presentations from  Zelira Therapeutics (ASX: ZLD), Argenica Therapeutics (ASX:AGN), WT Financial Group (ASX: WTL) & Celsius Resources Limited (...

ShareCafe ZLD 2 years ago
Market highlights and 5 ASX small caps to watch on Monday

Wall Street at fresh record highs All three key US benchmarks rose and reached fresh record highs on Friday, ahead of kick-off in earnings season. The Dow Jones was up by 1.30%, S&P 500 by 1.13%, and tech heavy Nasdaq by 0.98%. Bank sto...

Stockhead ZLD 2 years ago
Blazing it? How the top ASX cannabis shares performed in FY21

The 2021 financial year was overall a very good one for ASX shares. The S&P/ASX 200 Index (ASX: XJO) managed to put on a performance of 24% for the 12 months to 30 June 2021. That makes FY2021 one of the best financial years ever for t...

Motley Fool ZLD 2 years ago
Cannabis stocks celebrate Pershing ownership change

Cannabis stocks have welcomed the change in ownership of Pershing Australia from Bank of New York Mellon (BNYM) to Finclear Pty Ltd which – effective immediately – will allow the trading of cannabis securities on the ASX. In late 2019, BNYM...

Stockhead ZLD 2 years ago
Weed Week: Connecticut and Mexico on board cannabis bandwagon, as Rinehart enters the industry

Connecticut has become the latest US state to legalise recreational use of marijuana. The state’s governor has just signed a bill to allow people aged 21 and older to possess and consume marijuana, making it the 19th US state to do so. Here...

Stockhead ZLD 2 years ago
Weed Week: Amazon all-in on marijuana; free joints for jabs and Creso Pharma dual-listed in US

The US cannabis sector received a big lift after Amazon announced that job applicants at its offices and warehouses will no longer be drug-tested for marijuana use. Delivery drivers, however, will still be tested. The company also said it w...

Stockhead ZLD 2 years ago
Last Orders: ASX gains nearly 1 per cent back from the long weekend

The ASX 200 just closed 0.92 per cent up at 7,380 points  —  a new record high. The ASX Emerging Companies Index however fell 1.66 per cent, closing at 2,180. The best sector on the ASX was health which gained over 2 per cent while consumer...

Stockhead ZLD 2 years ago
Market highlights and 5 ASX small caps to watch on Tuesday

Wall Street mixed ahead as Nasdaq hits record highs Major indices in the US were mixed on Monday, with tech stocks leading the way, ahead of Thursday’s US Fed key policy meeting. The Dow Jones fell by 0.25%, S&P 500 rose by 0.18%, and t...

Stockhead ZLD 2 years ago
Building an export industry for cannabis medicines

The medicinal cannabis industry is gaining significant momentum, however, still remains in the early stages of growth. Zelira Therapeutics recently reported record quarterly cash receipts for the third quarter, up 249 per cent on H1 FY21. F...

Montgomery ZLD 2 years ago
Five ASX penny stocks making positive moves today

Summary Hillgrove Resources’ share price has skyrocketed 64.8% today and is currently trading at AU$0.089. Today, Veris’ share has given a breakout from a consolidation phase on the chart. The Red Sky Energy share price is also runnin...

Kalkine Media ZLD 2 years ago
Why are ASX healthcare shares Rhythm Biosciences and Zelira on the rise today?

Summary Diagnostics company Rhythm Biosciences has confirmed that LRF enhancements have shown to improve ColoSTAT® results. Cannabis medicines developer Zelira Therapeutics has entered into a partnership with Alternative Solutions for...

Kalkine Media ZLD 2 years ago
Why the Zelira (ASX:ZLD) share price is storming 7% higher

The Zelira Therapeutics Ltd (ASX: ZLD) share price is firmly in the green today following a positive update for its HOPE products. At the time of writing, the cannabis company’s shares are swapping hands for 5.7 cents, up 7.55%. What did Z...

Motley Fool ZLD 2 years ago
Market highlights and 5 ASX small caps to watch on Thursday

Dow Jones at record level, as US tech stocks sell off again The Dow Jones index has reached its all-time high, rising by 0.29% to finish at a record 34,230. However, tech stocks sold off again, with the likes of Amazon and Facebook falling...

Stockhead ZLD 2 years ago
How did Splitit Payments (ASX:SPT) fare in Q1 FY21?

Summary ASX-listed Splitit Payments Limited announced strong growth in Merchant Sales Volume (MSV) and revenue in Q1 FY2021. The Company’s brand awareness increased during the quarter, evident by the 70K increase in new shoppers. The...

Kalkine Media ZLD 2 years ago
Zelira (ASX:ZLD) share price falls despite strong trading update

The Zelira Therapeutics Ltd (ASX: ZLD) share price is lower during mid-afternoon trade despite announcing a positive trading update. At the time of writing, the cannabis company’s shares are fetching for 5.9 cents, down 1.67%. Q3 FY21 quar...

Motley Fool ZLD 2 years ago
Zelira announces record revenue in the march quarter

Zelira Therapeutics (ASX:ZLD) says it generated record quarterly product sales and licensing revenues of $225,000 for the March 2021 quarter, up 249 per cent from the previous six months.

BiotechDispatch ZLD 2 years ago
Market highlights and 5 ASX small caps to watch on Thursday

Wall Street mixed, even as banks’ earnings beat estimates US investors took the strong banks’ earnings in stride, with the major US indices petering out to a mixed finish. Major banks Goldman Sachs, JP Morgan and Wells Fargo unveiled quarte...

Stockhead ZLD 2 years ago
What will Elite Cannabinoids mean for ASX cannabis shares?

In what may be a catalyst for ASX cannabis shares, a private company today gained approval to grow medicinal cannabis in Western Australia. As reported by the ABC, the private medicinal cannabis company Elite Cannabinoids has received appr...

Motley Fool ZLD 3 years ago
The sector that’ll grow 480% this year, expert says

There is a sector in Australia that’s about to grow its revenue by 478% in the current financial year, according to one analyst. Consumer research firm IBISWorld revealed Tuesday that the medical cannabis manufacturing industry is currentl...

Motley Fool ZLD 3 years ago
5 top ASX cannabis shares in 2020

Investors in ASX cannabis shares have had a bumpy ride in 2020. Share prices were impacted by global oversupply issues in late 2019 then plunged in the March 2020 market downturn. But the Australian medical marijuana industry is building...

Motley Fool ZLD 3 years ago
Zelira Therapeutics Share Price Soars on Distribution Agreement

The share price of medical cannabis company Zelira Therapeutics Ltd (ASX:ZLD) has rocketed today thanks to a distribution agreement in the Washington DC area, US. At time of writing the ZLD share price is up 36.36% or 3.6 cents to trade at...

MoneyMorning ZLD 3 years ago
Here’s why the Zelira (ASX:ZLD) share price just rocketed to a new high

The Zelira Therapeutics Ltd (ASX: ZLD) share price is breaking new records today. This comes after the company announced a new licencing agreement with Alternative Solutions LLC. Alternative Solutions is a licenced grower, manufacturer and...

Motley Fool ZLD 3 years ago
Zelira shares soar after expanding US medical pot distribution

Shares in Zelira Therapeutics (ASX:ZLD) have risen more than 30 per cent to a nearly two-year high in early trade ... Read More The post Zelira shares soar after expanding US medical pot distribution appeared first on Stockhead.

Stockhead ZLD 3 years ago
Zelira Therapeutics’ (ASX:ZLD) September Quarter celebrates key milestones

Summary During September quarter, Zelira Therapeutics achieved significant milestones marking its successful transition to the ‘Launch, Learn and Develop’ model. Key developments include the launch of Zenivol™ in Australia and HOPE™ in...

Kalkine Media ZLD 3 years ago
Zelira Therapeutics (ASX:ZLD) sinks its teeth into US Oral Care Market with CBD toothpaste

Summary Zelira Therapeutics forays into the US oral care market by launching CBD toothpaste in partnership with US-based SprinJene®. The new CBD toothpaste will be Zelira’s first Over-the-Counter formulation. Further, the discussions...

Kalkine Media ZLD 3 years ago